Structural basis of Fumosorinone-mediated allosteric inhibition of PTP1B for cancer immunotherapy.

Zhang J, Lin L, Gong N, Li W, Liu Y, Sundarraj R, Li Y, Dong M, Ma J, Woycechowsky K, Mei K, Ge Y, Yuchi Z, Luo D

Open source

DOI
10.1038/s42003-026-10329-2
Published
2026 May 28
Container
Communications biology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s42003-026-10329-2,
  title = {Structural basis of Fumosorinone-mediated allosteric inhibition of PTP1B for cancer immunotherapy.},
  author = {Zhang J and Lin L and Gong N and Li W and Liu Y and Sundarraj R and Li Y and Dong M and Ma J and Woycechowsky K and Mei K and Ge Y and Yuchi Z and Luo D},
  year = {2026},
  journal = {Communications biology},
  doi = {10.1038/s42003-026-10329-2},
  url = {https://doi.org/10.1038/s42003-026-10329-2}
}

RIS

TY  - JOUR
TI  - Structural basis of Fumosorinone-mediated allosteric inhibition of PTP1B for cancer immunotherapy.
AU  - Zhang J
AU  - Lin L
AU  - Gong N
AU  - Li W
AU  - Liu Y
AU  - Sundarraj R
AU  - Li Y
AU  - Dong M
AU  - Ma J
AU  - Woycechowsky K
AU  - Mei K
AU  - Ge Y
AU  - Yuchi Z
AU  - Luo D
PY  - 2026
JO  - Communications biology
DO  - 10.1038/s42003-026-10329-2
UR  - https://doi.org/10.1038/s42003-026-10329-2
ER  - 

APA

J, Z., L, L., N, G., W, L., Y, L., R, S., Y, L., M, D., J, M., K, W., K, M., Y, G., Z, Y., & D, L. (2026). Structural basis of Fumosorinone-mediated allosteric inhibition of PTP1B for cancer immunotherapy.. Communications biology. https://doi.org/10.1038/s42003-026-10329-2

Source records